What Legend Biotech Corporation's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 2 | 5 |
| Total trades | 11 | 15 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 15 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Sanders Corazon (Corsee) D. | Director | Sep 29 | Open-market sale · S | −27,370 | $9.46 | −$259K | 52,731 |
| Casey Patrick John | Director | Sep 24 | Grant / award · A | +20,986 | — | — | 69,590 |
| Mao Li | Director | Sep 24 | Grant / award · A | +20,986 | — | — | 65,316 |
| Ji Darren Xiaohui | Director | Sep 24 | Grant / award · A | +28,330 | — | — | 92,103 |
| Sanders Corazon (Corsee) D. | Director | Sep 24 | Grant / award · A | +20,986 | — | — | 80,101 |
| Salovey Peter | Director | Sep 24 | Grant / award · A | +28,330 | — | — | 55,096 |
| Heyman Tomas J. | Director | Sep 24 | Grant / award · A | +20,986 | — | — | 53,720 |
| Santos Carlos E | Chief Financial Officer | Sep 21 | Sale for tax withholding · S | −5,430 | $9.14 | −$49.6K | 14,246 |
| Santos Carlos E | Chief Financial Officer | Sep 21 | Grant / award · A | +19,676 | — | — | 19,676 |
| Zhang Ingrid | Chief Executive Officer | Sep 15 | Grant / award · A | +1,131,860 | — | — | 1,131,860 |
| Bash Alan | Interim CEO | Aug 14 | Grant / award · A | +4,908 | — | — | 35,142 |
| Casey Patrick John | Director | Jun 30 | Open-market sale · S | −6,000 | $14.80 | −$88.8K | 48,604 |
| Huang Ying | Chief Executive Officer | Jun 30 | Gift · G | −3,382 | — | — | 238,490 |
| Huang Ying | Chief Executive Officer | Jun 25 | Open-market sale · S | −5,566 | $14.78 | −$82.3K | 241,872 |
| Huang Ying | Chief Executive Officer | Mar 25 | Open-market sale · S | −9,936 | $8.77 | −$87.1K | 247,438 |
Loading...
